1. Home
  2. NREF vs CVRX Comparison

NREF vs CVRX Comparison

Compare NREF & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NREF
  • CVRX
  • Stock Information
  • Founded
  • NREF 2019
  • CVRX 2000
  • Country
  • NREF United States
  • CVRX United States
  • Employees
  • NREF N/A
  • CVRX 206
  • Industry
  • NREF Real Estate Investment Trusts
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NREF Real Estate
  • CVRX Health Care
  • Exchange
  • NREF Nasdaq
  • CVRX Nasdaq
  • Market Cap
  • NREF 242.2M
  • CVRX 181.5M
  • IPO Year
  • NREF 2020
  • CVRX 2021
  • Fundamental
  • Price
  • NREF $14.77
  • CVRX $6.64
  • Analyst Decision
  • NREF Hold
  • CVRX Buy
  • Analyst Count
  • NREF 3
  • CVRX 7
  • Target Price
  • NREF $14.50
  • CVRX $14.50
  • AVG Volume (30 Days)
  • NREF 28.0K
  • CVRX 516.1K
  • Earning Date
  • NREF 05-01-2025
  • CVRX 05-08-2025
  • Dividend Yield
  • NREF 13.54%
  • CVRX N/A
  • EPS Growth
  • NREF N/A
  • CVRX N/A
  • EPS
  • NREF 2.59
  • CVRX N/A
  • Revenue
  • NREF $110,996,000.00
  • CVRX $52,870,000.00
  • Revenue This Year
  • NREF $25.18
  • CVRX $13.92
  • Revenue Next Year
  • NREF $3.65
  • CVRX $19.89
  • P/E Ratio
  • NREF $5.71
  • CVRX N/A
  • Revenue Growth
  • NREF 370.78
  • CVRX 25.62
  • 52 Week Low
  • NREF $12.14
  • CVRX $4.30
  • 52 Week High
  • NREF $18.09
  • CVRX $18.55
  • Technical
  • Relative Strength Index (RSI)
  • NREF 51.40
  • CVRX 46.55
  • Support Level
  • NREF $14.68
  • CVRX $6.08
  • Resistance Level
  • NREF $15.25
  • CVRX $7.17
  • Average True Range (ATR)
  • NREF 0.41
  • CVRX 0.59
  • MACD
  • NREF -0.01
  • CVRX 0.18
  • Stochastic Oscillator
  • NREF 35.71
  • CVRX 81.37

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: